 Independent Online | 'Cancer drug price dropped' Independent Online The department's deputy director general for regulation Anban Pillay said the drug rituximab, dubbed MabThera by Roche, had previously been too expensive ... State patients to benefit as Roche is persuaded to cut price of cancer ... |
